Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure
β Scribed by Maxwell, A. Peter
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 243 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of nifurtimox, a drug used in the treatment of Trypanosoma cruzi infections, has been studied in seven patients with chronic renal failure undergoing haemodialysis, and in seven healthy subjects. Each subject took nifurtimox 15 mg.kg-1 orally and blood samples were obtained for
## Background: Biochemical methods for estimating protein intake are based on the concept that nitrogen-containing products of protein in diet plus the products arising from endogenous protein are excreted as either urea or non-urea nitrogen (nun). this formulation is based on the fact that the ure
Erythrocyte 2,3-diphosphoglycerate (2,3-DPG ) and adenosinetriphosphate (ATP) levels were determined in 43 children with chronic renal failure on conservative treatment (CT), and 12 children on regular hemodialysis (HD) immediately before and after a HD session. The results were compared to non-anem
## Abstract A series of seven cases of acute renal failure is presented in which sonographic study of the kidneys provided diagnostic information not otherwise obtainable. Ultrasonic imaging should be among the first diagnostic procedures applied in cases of acute unexplained renal failure because